ALVAC-AIDSVAX Vaccine: Risk of Infection Reduced by 31%

  • Context: Undergrad 
  • Thread starter Thread starter Borek
  • Start date Start date
  • Tags Tags
    Vaccine
Click For Summary
SUMMARY

The ALVAC-AIDSVAX vaccine trial demonstrated a 31% reduction in the risk of HIV infection, with 51 infections in the vaccinated group of 8,197 participants compared to 74 infections in the control group of 8,198. Statistical analysis using both unequal and equal variance t-tests confirmed that the null hypothesis could be rejected, indicating a high degree of statistical significance in the difference between the two groups. The calculations involved Bernoulli trials and Binomial distributions to model infection probabilities and variances accurately.

PREREQUISITES
  • Understanding of Bernoulli trials and Binomial distributions
  • Familiarity with statistical significance and hypothesis testing
  • Knowledge of t-tests, both equal and unequal variance
  • Basic concepts of clinical trial design and analysis
NEXT STEPS
  • Study the principles of Bernoulli trials and their applications in clinical research
  • Learn how to perform and interpret t-tests in statistical software like R or Python
  • Explore confidence intervals and their significance in clinical trials
  • Investigate advanced statistical methods for analyzing clinical trial data
USEFUL FOR

Researchers, biostatisticians, and healthcare professionals involved in clinical trials, particularly those focused on vaccine efficacy and statistical analysis.

Borek
Mentor
Messages
29,204
Reaction score
4,626
It hit the news in a last few days, you have probably heard about it. That's what I have found about the trial:

New infections occurred in 51 of the 8,197 given vaccine and in 74 of the 8,198 who received dummy shots. That worked out to a 31 percent lower risk of infection for the vaccine group.

And it makes me wonder - what is statistical significance of this diference? What is a confidence level that those that were given vaccine were in fact more immune? Or in other words - what is a confidence level that probability of contracting AIDS was lower in those that received vaccine? (Sure, we have to assume both group were otherwise identical).

In theory I should know how to calculate it, but after 20 years of lying somewhere in the dark corner my statistics is so rusty I prefer not to touch it, as it may fall apart
 
Physics news on Phys.org
There are two groups: control vs. experiment.

If a group consists of N total individuals, n of whom were infected, then each individual within that group can be modeled as a Bernoulli trial with mean p = n/N and variance = p(1-p). A Bernoulli trial is an individual "experiment" with probability p of getting infected.

N trials are distributed Binomial with mean = Np = n and variance = Np(1-p) for the group as a whole.

Control group (m = 74, M = 8198):
...For an individual:
...Bernoulli probability: p = m/M = 0.00902659
...For the group:
...Binomial mean: m = 74
...Binomial variance: u = Mp(1-p) = 73.332.
Experiment group (n = 51, N = 8197)
...For an individual:
...Bernoulli probability: q = n/N = 0.00622179
...For the group:
...Binomial mean: n = 51
...Binomial variance: v = Nq(1-q) = 50.6827.

Unequal variances t-test:
...s = Sqrt[(Nu+Mv)/(MN)] = 0.122997
...t = (m - n)/s = 186.997
...d.f. = (u/M + v/N)^2 / ((u/M)^2/(M - 1) + (v/N)^2/(N - 1)) = 15,864.5
...The null hypothesis "true m = true n" can be rejected at a very high degree of statistical significance.

Equal variance t-test:
...S = Sqrt[((M-1)u+(N-1)v)/(M+N-2)] = 7.8745
...s = S Sqrt[1/M + 1/N] = 0.122998
...t = (m - n)/s = 186.995
...d.f. = M + N - 2 = 16,393
...Again, the null hypothesis "true m = true n" can be rejected at a very high degree of statistical significance.
 
Last edited:
Many thanks.
 

Similar threads

  • · Replies 100 ·
4
Replies
100
Views
10K
  • · Replies 42 ·
2
Replies
42
Views
10K
  • · Replies 20 ·
Replies
20
Views
3K
  • · Replies 2 ·
Replies
2
Views
2K
Replies
56
Views
7K
  • · Replies 201 ·
7
Replies
201
Views
22K
  • · Replies 287 ·
10
Replies
287
Views
28K
  • · Replies 516 ·
18
Replies
516
Views
39K
  • · Replies 26 ·
Replies
26
Views
5K
  • · Replies 1 ·
Replies
1
Views
5K